Top compounds associated with response to SLC10A2


Feature Type Standardized
Nominal ANOVA
mRNA brivanib CTRPv2 pan-cancer AAC -0.01 0.8
mRNA serdemetan FIMM pan-cancer AAC -0.046 0.8
mRNA NVP-BEZ235 CTRPv2 pan-cancer AAC -0.012 0.8
mRNA SB-431542 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.8
mRNA UNC0638 GDSC1000 pan-cancer AAC 0.008 0.8
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0092 0.8
mRNA Irinotecan CCLE pan-cancer AAC 0.015 0.8
mRNA decitabine CTRPv2 pan-cancer AAC 0.0074 0.8
mRNA T0901317 GDSC1000 pan-cancer AAC -0.0087 0.8
Download CSV